Early Phase 1 Long COVID Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 65 years old
- You are either a healthy volunteer OR you have been diagnosed with Long COVID (also called post-acute sequelae of SARS-CoV-2, or PASC)
- A specific genetic test (related to a protein called TSPO) shows you are a "high" or "mixed" affinity binder (this will be tested as part of screening)
- If you have Long COVID: you previously had a confirmed COVID-19 infection, and your neurological symptoms (such as brain fog, headaches, or other nerve-related issues) have been present for at least four weeks before joining the study
- If you are a healthy volunteer: you have no neurological symptoms
Who may not be able to join:
- You have a reason you cannot safely have an MRI scan (for example, certain metal implants)
- You are pregnant
- You are currently breastfeeding
- Your medical condition is too severe to take part in the imaging/scanning portion of the study
- You have a long-term infectious disease such as HIV or Hepatitis C
- You have had a viral or bacterial illness needing medical treatment or antibiotics within the past month
- You have been diagnosed with cancer, including leukemia
- You have a blood disorder or a blood clotting disorder
- You have an autoimmune disease — unless that condition is Multiple Sclerosis (MS), which is allowed
- A pregnancy hormone test (urine or blood) comes back positive on or just before the procedure day
- You are currently enrolled in another clinical trial using experimental treatments
- You are currently taking any experimental treatments
- The same TSPO genetic test shows you are a "low affinity binder" (confirm with trial site)
- You report a history of moderate or severe traumatic brain injury
- You report a history of whiplash injury
- You report a history of Inflammatory Bowel Disease (IBD) — note: Irritable Bowel Syndrome (IBS) with no signs of inflammation is generally allowed
- Your blood test results at screening fall outside acceptable ranges, including: high levels of inflammation markers, signs of infection or anemia, abnormal thyroid levels, fasting blood sugar above 100 mg/dL, or results suggesting organ damage (confirm specific values with trial site)
- You have used illegal substances within the past 6 months
- You have been diagnosed with Type 1 or Type 2 diabetes
- If you are a healthy volunteer: you regularly take over-the-counter anti-inflammatory medications, painkillers (other than aspirin), or sleep aids
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jonathan McConathy, MD, PhD, University of Alabama at Birmingham
Phone: 205-9961082
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Measurement of regional brain TSPO levels using PET in participants with neurological PASC and healthy volunteers
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.